FindTrial
Sign In

A multicenter clinical study of artificial intelligence-based 18F-FDG PET/CT in the diagnosis, treatment and prediction of prognosis and outcome of Hodgkin lymphoma

A multicenter clinical study of artificial intelligence-based 18F-FDG PET/CT in the diagnosis, treatment and prediction of prognosis and outcome of Hodgkin lymphoma

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500101637
Enrollment
Unknown
Registered
2025-04-27
Start date
2024-09-01
Completion date
Unknown
Last updated
2025-05-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hodgkin lymphoma

Interventions

Observation group:None

Sponsors

West China Hospital of Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1.Confirmed diagnosis of Hodgkin's lymphoma; 2.18F-FDG PET/CT prior to treatment; 3.Complete clinicopathologic and follow-up data available.

Exclusion criteria

Exclusion criteria: 1.Patients with other types of lymphoid tumors; 2.Patients who did not undergo PET/CT; 3.Patients who had received prior antitumor therapy; 4.Incomplete clinical information or imaging data.

Design outcomes

Primary

MeasureTime frame
Overall survival;Progression-free survival;ROC curve;AUC value;—

Countries

China

Contacts

Public ContactTian Rong

West China Hospital of Sichuan University

rongtiannuclear@126.com+86 189 8060 1586

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026